Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tenon Medical, Inc.TNON · Entity 2063 | Chief Financial Officer | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tenon Medical, Inc.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,591 |
Reported balance
After 2026-09-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-08 · Exercise / conversion · Acquired 30 · Balance 2,591 F1: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. |
| Common StockSEC Table I · non-derivative | Direct | 2,580 |
Reported balance
After 2026-09-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-09 · Tax withholding · Disposed 11 · Balance 2,580 F3: These shares were sold to pay tax liability associated with the vesting of RSUs. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 60 |
Reported balance
After 2026-09-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-08 · Exercise / conversion · Disposed 30 · Balance 60 F1: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. F2: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
F3: These shares were sold to pay tax liability associated with the vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:01 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Tax withholdingCommon Stock | 11 | $3.45 | $37.95 |
DisclosureSEC source: 0001213900-26-098774 · ownership.xml · nonDerivative · entry 2 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,580 F3 · security: These shares were sold to pay tax liability associated with the vesting of RSUs. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:01 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-098774 · ownership.xml · derivative · entry 3 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. F1 · derivative.expiration_date: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:01 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-098774 · ownership.xml · nonDerivative · entry 1 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 30 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 30 shares of common stock of the Issuer on September 8, 2026, as adjusted for 1-for-35 reverse stock split of the Issuer's common stock effected on August 10, 2026. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 20:43 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Tax withholdingCommon Stock | 12,978 | $0.20 | $2,569.64 |
DisclosureSEC source: 0001213900-26-085232 · ownership.xml · nonDerivative · entry 2 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,602 F2 · security: These shares were sold to pay tax liability associated with the vesting of RSUs. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:43 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 58,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-085232 · ownership.xml · derivative · entry 3 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,987 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 58,987 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on July 31, 2026. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 58,987 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on July 31, 2026. F1 · derivative.expiration_date: Represents conversion of 58,987 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on July 31, 2026. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:43 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 58,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-085232 · ownership.xml · nonDerivative · entry 1 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 58,987 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on July 31, 2026. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:37 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-024143 · ownership.xml · derivative · entry 2 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,126 Underlying: Common Stock · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026. F1 · derivative.expiration_date: Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:37 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-024143 · ownership.xml · nonDerivative · entry 1 Williamson Kevin · CIK 0002037535 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Tax withholdingCommon Stock | 18,518 | $0.93 | $17,243.96 |
DisclosureSEC source: 0001213900-26-001468 · ownership.xml · nonDerivative · entry 2 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,552 F2 · security: These shares were sold to pay tax liability associated with the vesting of RSUs. Read SEC document |
| January 01, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 58,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001468 · ownership.xml · derivative · entry 3 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,987 Underlying: Common Stock · 58,987 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026. F1 · derivative.expiration_date: Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026. Read SEC document |
| January 01, 2026 Filed Jan 6, 2026 01:50 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 58,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-001468 · ownership.xml · nonDerivative · entry 1 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 21:09 UTC | Tenon Medical, Inc. TNON · Entity 2063 | GrantRestricted Stock Units · Derivative | 117,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-099210 · ownership.xml · derivative · entry 1 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,974 Underlying: Common Stock · 117,974 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026. F2 · derivative.expiration_date: Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026. Read SEC document |
| September 03, 2025 Filed Dec 19, 2025 22:38 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionRestricted Stock Units · Derivative | 2,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-123961 · ownership.xml · derivative · entry 3 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,167 Underlying: Common Stock · 2,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer. F1 · derivative.exercise_date: Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025. F4 · derivative.expiration_date: N/A Read SEC document |
| September 03, 2025 Filed Dec 19, 2025 22:38 UTC | Tenon Medical, Inc. TNON · Entity 2063 | Exercise / conversionCommon Stock | 2,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-123961 · ownership.xml · nonDerivative · entry 1 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025. Read SEC document |
| November 05, 2024 Filed Dec 19, 2025 22:38 UTC | Tenon Medical, Inc. TNON · Entity 2063 | GrantRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-123961 · ownership.xml · derivative · entry 2 Williamson Kevin · CIK 0002037535 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires not disclosed F2 · security: Represents a grant of 6,250 RSUs of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 2,083 RSUs on September 3, 2025; 1,041 RSUs on each of March 3, 2026, September 3, 2026, and March 3, 2027; and 1,044 on September 3, 2027. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Issuer. F2 · derivative.exercise_date: Represents a grant of 6,250 RSUs of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 2,083 RSUs on September 3, 2025; 1,041 RSUs on each of March 3, 2026, September 3, 2026, and March 3, 2027; and 1,044 on September 3, 2027. F4 · derivative.expiration_date: N/A Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.